Connect
MJA
MJA

Pharmaceutical preparations

Letters

Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality

Paul J Sambrook, B E Christopher Nordin and Alastair N Goss

Med J Aust 2011; 194 (1): 51-52

Letters

Managing residual risk in patients receiving statin therapy

Ian R Hamilton-Craig

Med J Aust 2011; 194 (1): 54

Letters

Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality

Philip N Sambrook, Jiang S Chen, Judy M Simpson and Lyn M March

Med J Aust 2011; 194 (1): 51-52

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Steven R A Simoens

Med J Aust 2011; 194 (1): 52-54

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Philip M Clarke and Edmund M Fitzgerald

Med J Aust 2011; 194 (1): 52-54

Letters

Managing residual risk in patients receiving statin therapy

Marilyn K Mann

Med J Aust 2011; 194 (1): 54

Book reviews

Creating and marketing illness

Greg Kyle

Med J Aust 2010; 193 (11): 708

Letters

Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure

Kate A Towers, Kimberley A Bardsley and Peter S Macdonald

Med J Aust 2010; 193 (9): 555

Supplement

Safer use of antimicrobials in hospitals: the value of antimicrobial usage data

Vicki McNeil, Marilyn Cruickshank and Margaret Duguid

Med J Aust 2010; 193 (8): S114 Free

Letters

Generic medicines literacy — minimising the potential for patient confusion

Linda V Graudins and Michael J Dooley

Med J Aust 2010; 193 (7): 427

Letters

Managing residual risk in patients receiving statin therapy

Brett D Montgomery

Med J Aust 2010; 193 (6): 375-376

Letters

Managing residual risk in patients receiving statin therapy

Ian R Hamilton-Craig

Med J Aust 2010; 193 (6): 375-376

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Philip M Clarke and Edmund M FitzGerald

Med J Aust 2010; 193 (3): 186-187

Editorials

Rosiglitazone and cardiovascular disease revisited

Timothy M E Davis and Johannes B Prins

Med J Aust 2010; 193 (3): 134-135

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Liliana Bulfone

Med J Aust 2010; 193 (3): 186-187

Letters

Antibiotic prophylaxis for cardiac surgery — are we getting it right?

Frank Shann

Med J Aust 2010; 193 (1): 62-63

Letters

Antibiotic prophylaxis for cardiac surgery — are we getting it right?

Keryn J Christiansen

Med J Aust 2010; 193 (1): 62-63

Snapshot

Christmas lights in the gastrointestinal tract

Yohan Chacko and Carolyn J Clark

Med J Aust 2010; 193 (1): 56 Free

Letters

A risk for returned travellers: the “post-antibiotic era”

Geethanie A T P Fernando, Peter J Collignon and Jan M Bell

Med J Aust 2010; 193 (1): 59

Notable case

Severe hypoglycaemia associated with ingesting counterfeit medication

Santosh K Chaubey, Kunwarjit S Sangla, Emershia N Suthaharan and Yong M Tan

Med J Aust 2010; 192 (12): 716-717 Free

Letters

Hydroxychloroquine retinopathy: screening needed to prevent blindness

Elvis Ojaimi, Robyn H Guymer, Tien Y Wong and C Alex Harper

Med J Aust 2010; 192 (11): 668-669

Letters

Hydroxycut hepatotoxicity

Ken J Harvey

Med J Aust 2010; 192 (11): 669-670

Letters

Computerised prescribing: assessing the impact on prescription repeats and on generic substitution of some commonly used antibiotics

David A Newby and Jane Robertson

Med J Aust 2010; 192 (9): 543-544

Letters

Computerised prescribing: assessing the impact on prescription repeats and on generic substitution of some commonly used antibiotics

Joan V Henderson, Christopher M Harrison and Helena C Britt

Med J Aust 2010; 192 (9): 543-544

Editorials

Generic medicines literacy — minimising the potential for patient confusion

Andrew J McLachlan

Med J Aust 2010; 192 (7): 368-369